Aptevo Therapeutics APVO
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2024Q4 | 4.31 | 101.11 | 97.97 | -6,382 | -6 | |
| 2024Q3 | 6.65 | 102.20 | 37.37 | -5,213 | -5 | |
| 2024Q2 | 11.32 | 102.40 | 145.39 | -6,024 | -6 | |
| 2024Q1 | 173.53 | 102.18 | -368.11 | -6,983 | -7 | |
| 2023Q4 | 294.67 | 103.03 | -236.92 | -6,384 | -6 | |
| 2023Q3 | 537.25 | 103.58 | -908.25 | -6,560 | -6 | |
| 2023Q2 | 2376.91 | 102.89 | 0.58 | -1814.65 | -8,178 | -8 |
| 2023Q1 | 3313.02 | -424.52 | 0.56 | 642.99 | -7,756 | 3 |
| 2022Q4 | 3777.01 | 148.83 | 1.85 | -1546.24 | -7,684 | -5 |
| 2022Q3 | 4949.18 | 99.68 | 2.42 | -2539.10 | -7,784 | -8 |
| 2022Q2 | 5828.32 | -27.14 | 2.54 | 9163.53 | -7,562 | 28 |
| 2022Q1 | 9556.48 | 71.25 | -2522.82 | -5,611 | -8 | |
| 2021Q4 | 12812.53 | 61.24 | -2067.26 | -4,040 | -6 | |
| 2021Q3 | 25136.65 | 67.12 | -2295.18 | -4,750 | -7 | |
| 2021Q2 | 36516.51 | 70.96 | -2848.71 | -5,722 | -8 | |
| 2021Q1 | 49687.21 | 89.80 | -2669.63 | -6,888 | -7 | |
| 2020Q4 | 59666.98 | 95.09 | -3125.80 | -6,819 | -7 | |
| 2020Q3 | 12372.96 | 89.90 | -3451.40 | -6,246 | -7 | |
| 2020Q2 | 13593.98 | 100.06 | -3386.28 | -6,807 | -7 | |
| 2020Q1 | 6023.68 | 76.21 | 1448.94 | -7,622 | 3 |